Non-suicidal self-injury (NSSI) is one of the most common mental health problems and growing public-health issues, coupled with a significant population-level burden among adolescents in both devel...
20 January 2025 in Balıkesir Üniversitesi Fen Bilimleri Enstitüsü Dergisi
Mesenchymal stem cells (MSCs) in synovial fluid (SF) actively participate in the regeneration process of healthy joints and have been defined as a good source of chondrocyte cells, which can be obtained by in vitro differentiation of stem cells. This cell population derived from synovial fluid shares cellular characteristics with bone marrow and synovial membrane MSCs with respect to their differentiation potency. Current cell isolation protocols for cartilage therapy mainly focus on the isolation of chondrocytes or MSCs from biological samples. However, the isolation of chondrocytes after the in vitro differentiation from MSCs has not been described in the literature. In this context, we defined a novel method based on Ficoll-Paque density gradient centrifugation for high-throughput isolation of differentiated chondrocytes from human synovial fluid mesenchymal stem cells (hSF-MSCs) without the requirement for cell labeling. In this study, terminally differentiated chondrocytes were obtained after 21 days of chondrogenic differentiation from hSF-MSCs and were isolated using this novel protocol. The isolated chondrocytes were later analyzed for cell viability and functionality by staining with Alcian Blue and by gene expression analysis for chondrocyte markers. In conclusion, the novel chondrocyte isolation method described here is capable of achieving low-cost efficiency. According to the minimal process principles, we hope that this protocol will find use in both translational research and routine clinical applications involving the differentiation and isolation of chondrocytes in vitro.
Objective: Nephrotoxicity is a major complication of gentamicin (GEN), which is widely used in the treatment of severe Gram-negative infections. As we know, treatment with liraglutide has been shown to reduce oxidative stress. Therefore, we evaluated the potential protective effect of liraglutide against GEN-induced nephrotoxicity in rats. Material And Methods: Twenty-eight rats were randomly divided into four groups: control group (Group 1); rats intraperitoneally injected with GEN (100 mg/kg/day; Group 2); rats treated with GEN plus distilled water (Group 3); and rats treated with GEN plus liraglutide (0.6 mg/kg/day; Group 4). After 15 days, the rats were sacrificed, their kidneys taken, and blood analysis performed. Tubular necrosis, interstitial fibrosis, and inducible nitric oxide synthetase (iNOS) scores were determined histopathologically in a part of the kidneys; malondialdehyde (MDA), reduced glutathione (GSH), E-cadherin and transforming growth factor β1 (TGF-β1) levels were determined in another part of kidneys. Results: The GSH levels in renal tissue of only GEN-treated rats were significantly lower than others, and the administration of liraglutide to rats significantly increased the level of GSH. The group that was given GEN plus liraglutide had significantly lower MDA, TGF - β1, and E - cadherin levels than that given GEN alone. The rats treated with GEN+liraglutide indicated less severe tubular necrosis and their glomeruli maintained a better morphology compared to the GEN group. iNOS expression was higher in the liraglutide administrated group than the group that applied only GEN. Conclusion: Liraglutide exerts protective effects on GEN-induced kidney damage by reducing oxidative stress in rat model.
Objective: This study aims to investigate the differentiation of the U937 cell line into M1-polarized macrophages using four protocols described in previous studies, but which have not been standardized on account of phenotypic plasticity and functional instability of macrophages. The resulting phenotypic alternations were characterized. By revealing the flow cytometric profiles of the M1-polarized macrophages, obtained by implementation of different chemical induction protocols on the cells, this study provides invaluable data on the use of in vitro models involving M1 polarized macrophages. Methods: Four different chemical induction strategies were implemented on U937 cells to obtain M1-polarized macrophages, each involving either phorbol-12-myristate-13-acetate (PMA) alone or combine with additional stimulants such as lipopolysaccharide (LPS) and interferon-gamma (IFN-γ). After differentiation, the expression of the macrophage-specific surface markers CD68 (M1) and CD206 (M2) was analyzed by flow cytometry, and the polarization trends were examined based on the expression of the associated markers. Results: A divergence in the M1-macrophage-specific cell surface marker was observed among the applied macrophage differentiation strategies. This finding indicates that the balance between pro-inflammatory (M1-like) and anti-inflammatory (M2-like) phenotypes is subject to variation depending on the applied protocol. Furthermore, differentiation strategies (2) yielded optimal results in terms of cells exhibiting the M1 polarized macrophage phenotype (61%). Conclusion: The findings indicate that non-standardized differentiation protocols result in the generation of distinct macrophage-like populations from U937 cells regarding polarization. These findings emphasize the importance of standardization in experimental designs and provide a framework for selecting appropriate differentiation methods in studies of macrophage biology.